Chongqing Lummy Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Chongqing Lummy Pharmaceutical has a total shareholder equity of CN¥2.1B and total debt of CN¥287.7M, which brings its debt-to-equity ratio to 13.6%. Its total assets and total liabilities are CN¥3.0B and CN¥854.3M respectively.
Key information
13.6%
Debt to equity ratio
CN¥287.72m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥926.83m |
| Equity | CN¥2.12b |
| Total liabilities | CN¥854.30m |
| Total assets | CN¥2.98b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300006's short term assets (CN¥1.8B) exceed its short term liabilities (CN¥686.2M).
Long Term Liabilities: 300006's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥168.1M).
Debt to Equity History and Analysis
Debt Level: 300006 has more cash than its total debt.
Reducing Debt: 300006's debt to equity ratio has reduced from 57.3% to 13.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 300006 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 300006 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 19.5% per year.